Akèy › Maladi ra
Etid klinik pou Maladi ra ap rekrite nan Etazini
33 etid pou Maladi ra ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA9 etid
- Chicago, IL8 etid
- Washington, DC8 etid
- Philadelphia, PA7 etid
- Cincinnati, OH5 etid
- Los Angeles, CA5 etid
- Columbus, OH4 etid
- Nashville, TN3 etid
- Houston, TX3 etid
- New York City, NY3 etid
- St. Louis, MO3 etid
- Seattle, WA3 etid
- Atlanta, GA3 etid
- Rochester, MN3 etid
- Pittsburgh, PA3 etid
- Durham, NC3 etid
Pa eta
- Colorado3 etid
- Distrik Columbia3 etid
- Florid4 etid
- Georgia3 etid
- Illinois8 etid
- Kalifòni10 etid
- Maryland6 etid
- Massachusetts11 etid
- Minnesota3 etid
- Missouri4 etid
- New York3 etid
- North Carolina6 etid
- Ohio8 etid
- Pennsylvania7 etid
- Tennessee5 etid
- Texas4 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of SGT-212 Gene Therapy in Friedreich's Ataxia
Ap rekriteFaz 1
Laj 18 a 40 · Tout sèks · Mizajou Sep 29, 2026 · NCT07180355RAPA-501 Therapy for ALS
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT04220190Diagnosis and Treatment of Patients With Inborn Errors of Metabolism
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 115 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT00369421Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 100 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT02543996A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06525636Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 100 Years · Tout sèks · Mizajou Sep 18, 2026 · NCT02450851Caregiving Networks Across Disease Context and the Life Course
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05007990Longitudinal Studies of Patient With FPDMM
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 100 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT03854318Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 1, 2026 · NCT06016946Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Aug 31, 2026 · NCT07556913Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Aug 31, 2026 · NCT06258902International Rare Brain Tumor Registry
Ap rekriteEtid obsèvasyon
Jiska laj 45 · Tout sèks · Mizajou Aug 7, 2026 · NCT05697874Stakeholders of Rare Diseases Informing Values In Neuroethics
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 13, 2026 · NCT07314736Evaluation of an Advanced Lower Extremity Neuroprostheses
Ap rekrite
Laj 21 a 75 · Tout sèks · Mizajou Jul 10, 2026 · NCT00623389A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07127978Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07123155Baker Gordon Syndrome Natural History Study
Ap rekriteEtid obsèvasyon
Laj 0 a 99 · Tout sèks · Mizajou Jun 3, 2026 · NCT06399952UW Undiagnosed Genetic Diseases Program
Ap rekriteEtid obsèvasyon
Jiska laj 100 · Tout sèks · Mizajou May 29, 2026 · NCT04586075Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou May 5, 2026 · NCT07128966A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Ap rekriteFaz 1/2
Laj 25 a 65 · Tout sèks · Mizajou May 5, 2026 · NCT06826612A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)
Ap rekriteFaz 1/2
30 Months · Tout sèks · Mizajou Apr 17, 2026 · NCT04998396Gene Discovery Core, The Manton Center
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Mar 25, 2026 · NCT02743845Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Feb 17, 2026 · NCT05528744MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Ap rekriteEtid obsèvasyon
Laj 7 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT07374107Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas
Ap rekriteVolontè an sante akeyi
1 Day – 90 Days · Tout sèks · Mizajou Jan 27, 2026 · NCT07102966Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.